June 19, 2018 | News Release Review

Newsworthy vitamin D research, accurately and cautiously explained by the American Cancer Society

This is a balanced and carefully written report on a newly published study linking vitamin D levels and colorectal cancer risk.

4 Star

Large international study links blood vitamin D levels to colorectal cancer risk

June 18, 2018 | News Release Review

Here’s a prime example of how Big Pharma issues misleading news releases to journalists

The news release implies that rivaroxaban was being compared to other anticoagulants when what was actually being compared was an early vs. late discharge strategy.

3 Star

XARELTO® (rivaroxaban) Associated with Significantly Reduced Time in Hospital and Decreased Costs Compared to Standard of Care in New Study of Patients with Low-Risk Pulmonary Embolism (PE)

June 14, 2018 | News Release Review

No, an asthma drug tested in mice does not bring ‘new hope’ for Alzheimer’s patients, at least not yet

Use of use of words like “breakthrough” and a phrase suggesting the drug offers “new hope” for patients detract from the cautious aspects of this release.

1 Star

Temple researchers reverse cognitive impairments in mice with dementia

June 12, 2018 | News Release Review

Big Mango claims daily mango eating reduces systolic blood pressure in healthy women, but any fruit might do

Without a control group in the study to prove otherwise, it’s possible the consumption of two cups of any fruit, or even any food, may affect systolic blood pressure.

1 Star

Mangoes helped improve cardiovascular and gut health in women

June 8, 2018 | News Release Review

A new antibiotic alternative for acne? This study recap sends misleading messages

This release calling on dermatologists to prescribe spironolactone as an alternative to oral antibiotics for acne treatment is missing several key pieces of information including evidence, benefits, cost and potential harms.

2 Star

Spironolactone may be an alternative to antibiotics in women's acne treatment

June 5, 2018 | News Release Review

ASCO offers a positive spin on cancer drug survival stats while downplaying severe side effects

While researchers saw slightly slower cancer growth, patients receiving immunotherapy on average felt worse, while not living any longer.

3 Star

Adding Atezolizumab Immunotherapy to Chemotherapy Slows Growth of Advanced Squamous Lung Cancer

May 31, 2018 | News Release Review

Recap of small study on schizophrenia diagnostic device offers false hope

The release doesn’t mention costs or study limitations, and the lead offers false hope by stating that a device “common in optometrists’ offices” may be the key to faster schizophrenia diagnosis.

1 Star

Promise of faster, more accessible schizophrenia diagnosis, Rutgers study shows

May 30, 2018 | News Release Review

Janssen’s claim that Xarelto benefits frail patients better than warfarin built on frail research

The release appears to claim definitively that the research proves that Janssen’s anticoagulant is better — a claim not supported by the research — but it’s a message that’s left with readers.

2 Star

New Real-World Study Finds Long-Term XARELTO® (rivaroxaban) Use Resulted in Fewer Strokes and Systemic Emboli Compared to Warfarin in Frail Patients with Non-Valvular Atrial Fibrillation

May 24, 2018 | News Release Review

Percutaneous coronary intervention (PCI) declared ‘better’ than drug therapy; readers worse off

The release also doesn’t mention potential harms of PCI, put the size of the benefit in context, or disclose conflicts of interest.

3 Star

Procedure plus medication is better than standard treatment for heart disease patients

May 24, 2018 | News Release Review

UCLA offers cautious framing on mouse study of ‘stroke neural repair’

Compared to many news releases we review that have to do with rodent research, this one was more cautious with its language than most.

3 Star

Mice regrow brain tissue after stroke with bioengineered gel

Toolkit

Tips & Resources for Analyzing Health Care Claims

View More

Toolkit